Total 151Articles, Present Page 8/16
-
81Advisory Committee Meeting Outcome on Pfizer's COVID-19 Vaccine [Press Release, Feb. 23, 2021][Press Release, Feb 23, 2021 / UnofficialTranslation] On February 22, the Ministry of Food and Drug Safety held the meeting of COVID-19 Vaccine Safety and ClinicalEfficacy Advisory Committee regarding clinical trial results of COMIRNATY Inj., Pfizer Korea's COVID-19 vaccine.
-
(2.23) Advisory Committee Meeting Outcome on Pfizer’s COVID-19 Vaccine.pdf
2021-03-02 -
-
80Strengthened Remote Inspection on Foreign Food Facility and Establishment in the COVID-19 Era [Press Release, Feb. 19, 2021][Press Release, Feb. 19, 2021 / unofficialtranslation] Strengthened Remote Inspection on Foreign Food Facility and Establishment in the COVID-19 Era: - Following last year's remote document review, remote video inspection will be part of the 2021 inspection plan
-
2.19 Strengthened Remote Inspection on Foregin Food Facility and Establishment in the COVID-19 Era.pdf
2021-02-24 -
-
79MFDS Approves the First National Lot Release of COVID-19 Vaccine [Press Release, Feb. 17, 2021][Press Release, Feb. 17, 2021 / unofficial translation] The MFDS approves national lot release of Korea AstraZeneca COVID-19 Vaccine Inj., doses for 787 thousand people.
-
2.17 National Lot Release of AstraZenecas COVID-19 Vaccine.pdf
2021-02-24 -
-
78MFDS, Spearheading Enhancement of COVID-19 Daily Quarantine Management in Meat Processing and Packaging Businesses [Press Release, Feb 15, 2021][Press Release, Feb 15, 2021 / unofficial translation] MFDS, Spearheading Enhancement of COVID-19 Daily Quarantine Management in Meat Processing and Packaging Businesses
-
(Press Release) MFDS_Daily Quarantine Management in Meat Processing and Packaging Businesses.pdf
2021-02-21 -
-
77MDFS grants Marketing Authorization for COVID-19 Vaccine Inj. [Press Release, Feb 10, 2021][Press Release, Feb 10, 2021 / unofficial translation ] MDFS grants Marketing Authorization for COVID-19 Vaccine Inj.
-
0210 Marketing Aurhorization for Korea AstraZeneca COVID19 vaccine.pdf
2021-02-10 -
-
76Meeting Results of the Central Pharmaceutical Advisory Committee for COVID-19 Therapeutics [Press Release, Jan 27, 2021][Press Release,Jan 27, 2021 / unofficial translation ] Meeting Results of the Central Pharmaceutical Advisory Committee for COVID-19 Therapeutics
-
(1.27) Meeting Results of the Central Pharmaceutical Advisory Committee for COVID-19 Therapeutics.pdf
2021-02-10 -
-
75MFDS begins review of Pfizer's COVID-19 vaccine [Press Release, Jan 25, 2021][Press Release, Jan 25, 2021 / unofficial translation ] MFDS Begins Review of Pfizer’s COVID-19 Vaccine - Rigorous Safety and Efficacy Assessment within 40 Days -
-
(1.25) MFDS Begins Review of Pfizer’s COVID-19 Vaccine.pdf
2021-02-10 -
-
74Updates on the approval and review of COVID19 therapeutics and vaccines(2) [Press Release, Jan 21 2021][Press Release, Jan 21 2021 / unofficial translation ] Updates on the approval and review of COVID19 therapeutics and vaccines (2)
-
(1.21) Updates on the approval and review of COVID19 therapeutics and vaccines.pdf
2021-02-10 -
-
73MDFS grants Marketing Authorization for COVID-19 treatment, Regkirona Inj. [Press Release, Feb 5, 2021][Press Release, Feb 5, 2021 / unofficial translation ] MDFS grants Marketing Authorization for COVID-19 treatment, Regkirona Inj. - Improving the clinical symptoms in outpatients with mild (high risk group) to moderate cases -
-
0205 Marketing Authorization for COVID-19 treatment, Regkirona Inj..pdf
2021-02-05 -
-
72Meeting Results of the Advisory Committee for the Safety and Efficacy Assessment of COVID-19 Therapeutics [Press Release, Jan 18, 2021][Press Release, Jan 18, 2021, unofficial translation] Meeting Results of the Advisory Committee for the Safety and Efficacy Assessment of COVID-19 Therapeutics - on the clinical test results of Celltrion’s monoclonal antibody therapeutics candidate (Regkirona Inj)
-
(1.18) Results of the Advisory Committee for the Safety and Efficacy Assessment of COVID-19 Therapeutics.pdf
2021-02-03 -